Risk Factors for Hyperuricemia with HMG-CoA Reductase Inhibitors Using a Postmarketing Surveillance Database in Japan
Author:
Affiliation:
1. Division for Evaluation and Analysis of Drug Information, Faculty of Pharmacy, Keio University
2. Department of Hygienic Chemistry, Faculty of Pharmacy, Keio University
3. Department of Cardiology, Tokyo Women's Medical University
Publisher
Japanese Society of Clinical Pharmacology and Therapeutics
Subject
Pharmacology (medical),Pharmacology
Link
https://www.jstage.jst.go.jp/article/jscpt/49/4/49_145/_pdf
Reference23 articles.
1. 1) Rogers AS. Adverse drug events: identification and attribution. Drug Intell Clin Pharm. 1987; 21 (11) : 915-20.
2. 2) Tomita M, Mizuno S, Yamanaka H, Hosoda Y, Sakuma K, Matuoka Y, et al. Does hyperuricemia affect mortality? A prospective cohort study of Japanese male workers. J Epidemiol. 2000; 10 (6) : 403-9.
3. 3) Reunanen A, Takkunen H, Knekt P, Aromaa A. Hyperuricemia as a risk factor for cardiovascular mortality. Acta Med Scand Suppl. 1982; 668:49-59.
4. 4) Levine W, Dyer AR, Shekelle RB, Schoenberger JA, Stamler J. Serum uric acid and 11.5-year mortality of middle-aged women: findings of the Chicago Heart Association Detection Project in Industry. J Clin Epidemiol. 1989; 42 (3) : 257-67.
5. 5) Lazzeri C, Valente S, Chiostri M, Sori A, Bernardo P, Gensini GF. Uric acid in the acute phase of ST elevation myocardial infarction submitted to primary PCI: its prognostic role and relation with inflammatory markers: a single center experience. Int J Cardiol. 2010; 138 (2) : 206-9. doi: 10.1016/j.ijcard.2008.06.024.
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3